Massachusetts Supreme Court throws out conviction of black man for unlawful firearm possession, on the basis that police didn't have probable cause to stop him. But the more interesting finding? That when a black man runs from police, he's not in and of itself giving enough evidence of guilt to constitute "probable cause" -- that he "might just as easily be motivated by the desire to avoid the recurring indignity of being racially profiled as by the desire to hide criminal activity." This is not "judicial activism," of course, but the application of common sense to the law -- which does not, and cannot, mandate that black men be suspected and stopped by police, after all.
The incomparable Dave Lindorff reminds us that Wells Fargo CEO John Stumpf has promised "accountability" and "taking responsibility" for his corporation's transgressions, but won't do anything that might suggest an actual commitment to accountability and responsibility, like resigning or giving back his unearned millions. Mr. Lindorff then imagines what that would be like if we all did that -- speeders can admit "accountability" and "responsibility" and then drive away, murderers can admit "accountability" and "responsibility" and then leave the courtroom untouched, and so on. But for many tax cheats, of course, this is already the reality -- as long as you're not one of the "little people," that is.
Mylan CEO Heather Bresch tells Congress that Mylan "only" makes $50 in profit per dose of EpiPen. Which almost certainly isn't true (surely Ms. Bresch counts overpaying herself as one of the "costs" that interfere with profits), but is rather beside the point -- if you sell millions of these every year, then you're still making a lot of money. Rep. Chaffetz (R-UT) gets in a lot of good shots during the hearing, but let's see if he supports any action afterward.
In other Mylan-related news, Mylan had some, ah, friends in high places helping it get the EpiPen into public schools -- none other than Gayle Manchin, head of the National Association of State Boards of Education, and, of course, the wife of Sen. Joe Manchin (D-WV) and, more interestingly, the mother of Mylan CEO Heather Bresch. How clever of Mrs. Manchin to put forward an initiative to get schools to keep more life-saving allergy medications on site -- and to get our government to give certain funding preferences to schools that complied! Still, this is a turd that can be polished by creating/allowing more competition for the EpiPen. That wouldn't be the only happy ending to this story, though -- when Sen. Manchin gets blown out in his re-election effort in 2018, he'll get to annoy his wife and daughter a lot more.
Finally, a solid one-third of U.S. Senators go on record supporting a public health care option, but Democrat "moderates" up for re-election in 2018 sound far more skeptical. How many times must I tell these pimps! They will not lose re-election because they support a public health care option, they'll lose because they oppose it -- poll after poll tells us that a majority of Americans support a single-payer system, which is rather to the left of a public option. The three Senators named -- Heidtkamp of North Dakota, Tester of Montana, and McCaskill of Missouri -- are all toast in 2018, if they insist on taking the road of cowardice.